Preparation method of Anqi flat-pressing capsule

By combining the traditional Chinese medicine formula of Anqi Pingya Capsules with the Western medicine nimodipine, the problem of large side effects of existing antihypertensive drugs has been solved, achieving efficient and stable blood pressure control and protection of cardiac function, enhancing the effect of antihypertensive drugs and prolonging the antihypertensive time.

CN121041386APending Publication Date: 2025-12-02王英会
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511304323.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-09-12
Publication Date
2025-12-02

AI Technical Summary

Technical Problem

Existing antihypertensive drugs have significant side effects and poor efficacy in treating hypertension, especially Western medicines such as antagonists, ion pumps, angiotensin, and diuretics, which may cause adverse reactions such as ventricular suffocation, respiratory arrest, muscle fasciculations, increased intraocular pressure, dehydration, and hypokalemia during use.

Method used

The formula of Anqi Pingya Capsules includes traditional Chinese medicine ingredients such as Astragalus membranaceus, Codonopsis pilosula, Salvia miltiorrhiza, Paeonia suffruticosa, malt, hawthorn, Scutellaria baicalensis, Bupleurum chinense, and Isatis indigotica. These ingredients are dried, ground into fine powder, mixed, and made into 0.5g/capsule dosage form. When used in combination with the Western medicine nimodipine, it can achieve the effects of nourishing the heart and calming the mind, promoting blood circulation and removing blood stasis, soothing the liver and relieving depression, regulating qi, and lowering blood pressure.

Benefits of technology

This capsule not only improves the efficacy of antihypertensive drugs and prolongs the duration of blood pressure reduction, but also eliminates the side effects of Western medicine, achieving blood pressure stability and protecting heart function, and reducing the risk of hypertension recurrence.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the field of traditional Chinese medicines, in particular to a preparation method of an Anqi flat-pressing capsule which comprises the following components in parts by weight: 6-7 parts of astragalus membranaceus, 6-7 parts of codonopsis pilosula, 4g of salvia miltiorrhiza, 5-6 parts of cortex moutan, 5-6 parts of malt, 5-6 parts of hawthorn, 3-4 parts of scutellaria baicalensis, 3-4 parts of radix bupleuri, 2.5 g of diazepam, 1-2 parts of nimodipine and 2-3 parts of radix isatidis. The capsule has the effects of nourishing heart, stabilizing mind, promoting blood circulation to remove blood stasis, soothing liver-qi stagnation, dredging and regulating internal organs, regulating qi activity, reducing heart pressure, maintaining normal functions of the heart, enabling qi and blood to be smooth and smooth, coordinating functions of the internal organs, reducing resistance and reducing blood pressure, so that the heart is protected against mind, and the main mind is relieved if the main mind is relieved. The capsule has the advantages of normal heart function, reduced pressure, relatively stable blood pressure, smooth qi and blood, healthy body and no occurrence of diseases, can be used for treating various hypertension and intractable hypertension diseases, and has no side effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of traditional Chinese medicine, and in particular to a method for preparing Anqi Pingya Capsules. Background Technology

[0002] While people's material living standards have improved, the problem of overnutrition has become more serious. As a result, the number of patients with hypertension has been increasing year by year in recent years, and the trend is towards younger patients. This has led to a high mortality and disability rate of cardiovascular and cerebrovascular diseases, which has further highlighted their harm to society and put great pressure and burden on families and society.

[0003] The heart is the sovereign organ, the abode of the spirit; when the sovereign is wise, the subjects are at peace; when the sovereign is unwise, all twelve officials are in danger. Current antihypertensive drugs primarily target the outer periphery of blood vessels, such as antagonists, ion pumps, angiotensin receptor blockers, and diuretics. Antagonists can cause adverse reactions including ventricular or respiratory arrest, muscle fasciculations, and increased intraocular pressure. Diuretics can lead to a drop in blood pressure and dehydration; most diuretics, except for potassium-sparing diuretics, cause hypokalemia. Therefore, current technologies not only have poor curative effects but also introduce side effects.

[0004] To address these issues, we propose a preparation method for Anqi Pingya Capsules. Summary of the Invention

[0005] The purpose of this invention is to provide a method for preparing Anqi Pingya Capsules to solve the problems mentioned in the background art.

[0006] To achieve the above objectives, the present invention provides the following technical solution:

[0007] A method for preparing Anqi Pingya Capsules includes the following components in parts by weight: Astragalus membranaceus 6-7 parts, Codonopsis pilosula 6-7 parts, Salvia miltiorrhiza 4g, Paeonia suffruticosa 5-6 parts, Hordeum vulgare 5-6 parts, Crataegus pinnatifida 5-6 parts, Scutellaria baicalensis 3-4 parts, Bupleurum chinense 3-4 parts, Diazepam 2.5g, Nimodipine 1-2 parts, and Isatis indigotica 2-3 parts.

[0008] In a further embodiment, the Anqi Pingya capsule comprises the following components by weight: Astragalus membranaceus 6.25 parts, Codonopsis pilosula 6.25 parts, Salvia miltiorrhiza 4g, Paeonia suffruticosa 6 parts, Hordeum vulgare 6 parts, Crataegus pinnatifida 6 parts, Scutellaria baicalensis 4 parts, Bupleurum chinense 4 parts, Diazepam 0.25 parts, Nimodipine 2 parts, and Isatis indigotica 3 parts.

[0009] In a further embodiment, the following steps are included:

[0010] Step (1): Dry and grind the raw materials into fine powder and pass them through a mill. Then, take each raw material according to the weight ratio and mix them evenly to obtain an intermediate.

[0011] Step (2): The intermediate obtained in step (1) is packaged into empty capsules.

[0012] Step (3): The Anqi Pingya capsules prepared using the above method are 0.5g / capsule.

[0013] Compared with the prior art, the beneficial effects of the present invention are:

[0014] Astragalus: It has a sweet taste and slightly warm nature. It enters the spleen and lung meridians. It tonifies qi and strengthens the exterior, promotes the elimination of toxins and pus, promotes urination, and promotes tissue regeneration.

[0015] Codonopsis pilosula: It is sweet in taste and neutral in nature. It enters the spleen and lung meridians and has the functions of tonifying the middle energizer and replenishing qi, quenching thirst, strengthening the spleen and benefiting the lungs, nourishing blood and promoting body fluids.

[0016] Salvia miltiorrhiza: bitter in taste, slightly cold in nature, enters the heart and liver meridians, invigorates blood circulation and removes blood stasis, regulates menstruation and relieves pain, clears the heart and relieves irritability, cools the blood and eliminates carbuncles.

[0017] Moutan bark: It tastes bitter and pungent, and is slightly cold in nature. It enters the heart, liver, and kidney meridians and has the effects of clearing heat and cooling blood, and promoting blood circulation and removing blood stasis.

[0018] Malt: It has a sweet taste and neutral properties. It enters the spleen and stomach meridians. It promotes qi circulation and digestion, strengthens the spleen and stomach, and reduces lactation and bloating.

[0019] Hawthorn: Sour and sweet, slightly warm, enters the spleen, stomach, and liver meridians, promotes digestion and strengthens the stomach, regulates qi and disperses blood stasis, and clears turbidity and lowers lipids.

[0020] Scutellaria baicalensis: bitter in taste, cold in nature, enters the lung, gallbladder, spleen, large intestine and small intestine meridians. It clears heat and dries dampness, drains fire and detoxifies, stops bleeding and calms the fetus.

[0021] Bupleurum: It has a pungent and bitter taste, is slightly cold in nature, and enters the liver, gallbladder, and lung meridians. It harmonizes the exterior and interior, soothes the liver and relieves depression, raises yang and lifts prolapse, and reduces fever and stops malaria.

[0022] Isatis root: bitter in taste, cold in nature, enters the heart and stomach meridians, clears heat and detoxifies, cools the blood, and soothes the throat.

[0023] This capsule works by nourishing the heart and calming the mind, promoting blood circulation and removing blood stasis, soothing the liver and relieving depression, regulating the internal organs, regulating Qi, reducing cardiac pressure, and maintaining normal heart function. It ensures smooth flow of Qi and blood, coordinates the functions of the internal organs, reduces resistance, and lowers blood pressure, thus protecting the heart from losing its vital functions. When heart function is normal and pressure is reduced, blood pressure is relatively stable, Qi and blood flow smoothly, the body is healthy, and many diseases are prevented.

[0024] This capsule is also used for various types of hypertension and refractory hypertension. When various antihypertensive drugs are ineffective (excluding organic hypertension such as tumors, polycystic kidney disease, or physiological hypertension), adding Anqi Pingya capsules to the appropriate antihypertensive drugs results in significantly better effects than taking the antihypertensive drugs alone. Anqi Pingya capsules act as a synergist, not only improving the efficacy of antihypertensive drugs but also eliminating the side effects of Western medicine, making it an ideal match for nifedipine-type drugs. This capsule not only improves efficacy but also prolongs the duration of blood pressure reduction.

[0025] The compatibility principle is as follows: Astragalus and Codonopsis are the principal herbs, hawthorn, malt, and Salvia miltiorrhiza are the assistant herbs, Scutellaria baicalensis, Bupleurum chinense, and Isatis indigotica are the adjuvant herbs, and Paeonia suffruticosa is the guiding herb. Astragalus and Codonopsis pilosula tonify Qi, while Salvia miltiorrhiza and Paeonia suffruticosa invigorate blood, cool the blood, and tonify blood. Cooling the blood requires clearing the fire in the heart, invigorating blood and removing blood stasis to remove impurities in the blood. When blood stasis is cleared and Qi is sufficient, Qi and blood flow smoothly. Salvia miltiorrhiza enters the heart meridian, invigorating blood and removing blood stasis. With no impurities in the blood, blood flows more smoothly in the blood vessels, reducing resistance and lowering the pressure on the blood vessels. Naturally, Qi and blood flow smoothly, and blood pressure decreases. Blood stasis causes blood vessel blockage, increases pressure, and raises blood pressure. Just as water rises when a riverbed is stagnant, causing blockages or even overflows, blood stasis in the human blood vessels causes emboli or blockages, leading to bleeding. This is an analogy for the harm of hypertension. Malt and hawthorn are used as adjuvants to regulate and nourish the spleen and stomach, aid digestion, and enhance the source of qi and blood production. Scutellaria baicalensis and Isatis indigotica are used to clear heat, purge fire, and cool the blood, and licorice is added to harmonize the various herbs. Diazepam is added to relieve emotions and calm the mind, while nimodipine relieves spasms; the two combined help lower blood pressure. Since tonifying qi and clearing heat avoids the problem of excessive heart fire, the combined effects nourish the heart and stabilize the mind, invigorate blood and remove blood stasis, resulting in abundant qi and blood. This promotes smooth and unobstructed flow of qi. Bupleurum chinense unblocks the qi mechanism, connecting the upper and lower parts of the body, maintaining the normal ascending and descending functions of the internal organs.

[0026] The traditional Chinese medicine preparation of this invention is an indivisible complete composition. Each herb plays a vital role in the composition. Each herb complements the others, not only exerting its own efficacy but also promoting the efficacy of other herbs and suppressing side effects. This is the result of long-term summarization. The dosage of each herb determines the efficacy of the entire preparation. When prescribing the medicine, based on the understanding of hypertension in traditional Chinese medicine, the medicine carefully selects myocardial protective drugs while also incorporating the principles of promoting blood circulation, cooling blood, regulating qi, and unblocking collaterals.

[0027] This capsule nourishes the heart and calms the mind, regulates the lungs and internal organs, and harmonizes the flow of Qi and blood to protect the heart and maintain its function of nourishing the spirit. This ensures that when the heart is clear, the body is at peace, and blood pressure remains stable, preventing various diseases. Blood stasis causes blocked blood vessels, increasing pressure and raising blood pressure. Once the blood stasis is removed, blood circulates freely throughout the body, reducing resistance and lowering blood pressure. Detailed Implementation

[0028] The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of the present invention.

[0029] In this embodiment of the invention, a method for preparing anastomosis-relieving capsule is described:

[0030] Example 1: Astragalus membranaceus 6g, Codonopsis pilosula 6g, Salvia miltiorrhiza 4g, Paeonia suffruticosa 5g, Hordeum vulgare 5g, Crataegus pinnatifida 5g, Scutellaria baicalensis 3g, Bupleurum chinense 3g, Diazepam 0.2g, Nimodipine 1g, Isatis indigotica 2g. The raw materials were dried, ground into fine powder and sieved. Then, each raw material was taken according to the weight ratio and mixed evenly to obtain an intermediate, which was then packaged into 0.5g empty capsules.

[0031] Example 2: Astragalus membranaceus 7g, Codonopsis pilosula 7g, Salvia miltiorrhiza 4g, Paeonia suffruticosa 6g, Hordeum vulgare 6g, Crataegus pinnatifida 6g, Scutellaria baicalensis 4g, Bupleurum chinense 4g, Diazepam 0.5g, Nimodipine 2g, Isatis indigotica 3g. The raw materials were dried, ground into fine powder and sieved. Then, each raw material was taken according to the weight ratio and mixed evenly to obtain an intermediate, which was then packaged into 0.5g empty capsules.

[0032] Example 3: Astragalus membranaceus 6.5g, Codonopsis pilosula 6.5g, Salvia miltiorrhiza 6.5g, Paeonia suffruticosa 5.5g, Hordeum vulgare 5.5g, Crataegus pinnatifida 5.5g, Scutellaria baicalensis 3.5g, Bupleurum chinense 3.5g, Diazepam 0.3g, Nimodipine 1.5g, Isatis indigotica 2.5g. The raw materials were dried, ground into fine powder and sieved. Then, each raw material was taken according to the weight ratio and mixed evenly to obtain an intermediate, which was then packaged into 0.5g empty capsules.

[0033] Example 4: Astragalus membranaceus 6.25g, Codonopsis pilosula 6.25g, Salvia miltiorrhiza 4g, Paeonia suffruticosa 6g, Hordeum vulgare 6g, Crataegus pinnatifida 6g, Scutellaria baicalensis 4g, Bupleurum chinense 4g, Diazepam 0.25g, Nimodipine 2g, Isatis indigotica 3g. The raw materials were dried, ground into fine powder and sieved. Then, each raw material was taken according to the weight ratio and mixed evenly to obtain an intermediate, which was then packaged into 0.5g empty capsules.

[0034] Clinical trials:

[0035] The traditional Chinese medicine preparation for treating hypertension in this invention was obtained through long-term and extensive research and continuous improvement by the inventor. It was used to treat 575 confirmed patients, of whom 115 patients who were originally taking Western medicine to lower their blood pressure continued to take Western medicine. This group served as the control group.

[0036] 115 patients took 2 tablets of compound reserpine, 1 tablet of indapamide, and 1 capsule of Anqiping pressure capsule from Example 1. This group was the experimental group 1.

[0037] 115 patients took 2 tablets of compound reserpine, 1 tablet of indapamide, and 1 capsule of Anqiping pressure capsule from Example 2. This group was the experimental group 2.

[0038] 115 patients took 2 tablets of compound reserpine, 1 tablet of indapamide, and 1 capsule of Anqiping pressure capsule (Example 3). This group was the experimental group 3.

[0039] 115 patients took 2 tablets of compound reserpine, 1 tablet of indapamide, and 1 capsule of Anqiping pressure capsule (Example 4). This group was the experimental group 4.

[0040] The five groups of patients shared similar basic characteristics, including age, gender, and disease duration. Furthermore, none of the patients had hypertension caused by organic lesions, such as polycystic kidney disease or tumors, or physiological hypertension (i.e., a family history of the condition).

[0041] The criteria for evaluating the efficacy of the medication are as follows:

[0042] Significant effect (cure): The patient's blood pressure has remained below 130 / 85 mmHg for more than one year and there are no symptoms of hypertension;

[0043] Effective: The patient's blood pressure has been controlled below 130 / 85 mmHg for more than six consecutive months, and there are no symptoms of hypertension;

[0044] Ineffective: Blood pressure is not under control and there are symptoms of hypertension.

[0045] The following is a clinical trial efficacy evaluation table.

[0046] Group Effective efficient invalid cure rate Overall efficiency control group 84 15 16 73.04% 86.09% Experiment 1 group 109 4 2 94.48% 98.26% Experimental Group 2 111 2 2 96.52% 98.26% Experiment 3 groups 110 3 2 95.65% 98.26% Experiment 4 groups 112 2 1 97.39% 99.13%

[0047] The Anqi Pingya Capsules of this invention nourish the heart and calm the mind, promote blood circulation and remove blood stasis, soothe the liver and relieve depression. They mainly lower blood pressure by reducing the pressure on the inner wall of blood vessels. Anqi Pingya Capsules act as an synergist, not only improving the efficacy of antihypertensive drugs, but also prolonging the antihypertensive time. Follow-up visits showed no recurrence, blood pressure remained stable, and no other abnormal side effects occurred.

[0048] Typical cases and treatment effects:

[0049] Case 1: Mr. Wang, male, 65 years old, from Qianmotou Town, Shenzhou City, Hebei Province, visited our clinic in 2017. His blood pressure was diagnosed as 190 / 120 mmHg. The patient reported that since the age of 45, his blood pressure had consistently hovered around 200 / 140 mmHg. He frequently experienced dizziness, palpitations, and shortness of breath. He regularly took antihypertensive medications, including compound reserpine tablets, nimodipine tablets, nifedipine tablets (including sustained-release tablets), and indapamide tablets, alternating between single and combined use. However, his blood pressure remained unstable, fluctuating but always hovering at a high level. Additionally, when taking nifedipine, he experienced palpitations, facial flushing, burning sensation, irritability, and lower limb edema. He was prescribed two compound reserpine tablets, one indapamide tablet, and one Anqi Pingya capsule (Example 4), once nightly. Three days later, at 6:30 AM, his blood pressure was measured at 120 / 70 mmHg, with no other abnormal side effects, and his mental state was good. After 30 days of consistent use of the above medications, the patient's blood pressure remained around 120 / 70 mg / hg without any discomfort. At this point, the Western medicine was discontinued, and the patient continued taking Anqi Pingya Capsules for 60 days. The blood pressure remained stable with no further discomfort. Follow-up visits showed that the patient's blood pressure remained around 120 / 70 mg / hg for over a year without any symptoms of hypertension.

[0050] Case 2: Mr. Zhang, male, 55 years old, from Qianmotou Town, Shenzhou City, Hebei Province, visited our clinic in 2018. His blood pressure was diagnosed as 180 / 100 mmHg. The patient reported dizziness, tinnitus, neck discomfort, memory loss, poor concentration, and insomnia for three years. He had previously taken nifedipine controlled-release tablets, amlodipine besylate tablets, and valsartan capsules, and reported fatigue and diarrhea after taking valsartan capsules. He took two tablets of compound reserpine, one tablet of indapamide, and one capsule of Anqi Pingya capsule (Example 4). Five days later, his blood pressure was measured at 6:30 AM at 130 / 70 mmHg, with no discomfort. After continuing to use the above medications for 30 days, his blood pressure remained around 130 / 70 mmHg without discomfort. He then discontinued the Western medicine and continued taking Anqi Pingya capsules for 60 days, after which his blood pressure stabilized without further discomfort. Follow-up showed that the patient's blood pressure remained below 130 / 85 mgHg for more than a year and there were no symptoms of hypertension.

[0051] Case 3: Ms. Wang, female, 60 years old, from Dong'anzhuang Township, Shenzhou City, Hebei Province, visited our clinic in 2017. Her blood pressure was diagnosed as 200 / 120 mmHg. The patient reported dizziness, headaches, and memory loss for ten years, and had previously taken compound reserpine tablets, nimodipine tablets, amlodipine besylate tablets, and valsartan capsules. After taking two compound reserpine tablets, one indapamide tablet, and one Anqi Pingya capsule (Example 3), her blood pressure was measured at 130 / 80 mmHg at 6:30 AM seven days later, with no discomfort. After continuing to use the above medications for 30 days, her blood pressure remained around 130 / 80 mmHg without discomfort. She then discontinued the Western medicine and continued taking Anqi Pingya capsules for 60 days, after which her blood pressure stabilized without discomfort. Follow-up showed that the patient's blood pressure remained below 130 / 85 mmHg for more than a year, and she had no symptoms of hypertension.

[0052] Case 4: Ms. Wang Yingfang, 62 years old. She visited my clinic in 2005 complaining of dizziness, insomnia, bitter taste in the mouth, dry throat, poor appetite, and fatigue. Her blood pressure was 215 mmHg systolic and 130 mmHg diastolic. Her tongue was red and dry, her left pulse was wiry and forceful, and her right pulse was thin and rapid. The diagnosis was excessive liver fire and liver yang rising. She was prescribed Anqi Pingya Capsules along with appropriate antihypertensive medication. After three days, she reported significant improvement, with her blood pressure measured at 130 mmHg systolic and 85 mmHg diastolic. She continued the original prescription, taking one Anqi Pingya Capsule nightly to stabilize her blood pressure. Since then, her blood pressure has remained stable and has not risen again.

[0053] Case 5: Zhang Lingcui, female, 58 years old. Presented in February 2012. Chief complaint: fluctuating blood pressure, dizziness, vertigo, hearing loss, dry throat, insomnia, poor appetite, fatigue, daytime lethargy, and lack of motivation. Blood pressure: 185 mmHg systolic, 102 mmHg diastolic. Examination revealed a wiry and forceful pulse on the left and a deep and wiry pulse on the right. Tongue: red with little white coating, thick and greasy in the center. Diagnosis: liver qi stagnation, spleen dampness transforming into fire, leading to liver yang rising upwards, causing dizziness and other concurrent symptoms. She took one Anqi Pingya capsule nightly, after which all symptoms disappeared, and she returned to normal, remaining symptom-free for several years.

[0054] Case 6: Wang Cunzhi, male, 72 years old, from Hutouwang, Qianmotou Town, Shenzhou City, Hebei Province, came to our clinic on April 16, 1971. His chief complaints were bitter taste in the mouth, dry throat, poor appetite, fatigue, and weakness. His tongue was red with little white coating and thick, greasy coating in the middle. He was diagnosed with liver qi stagnation and was prescribed one capsule of Anqi Pingya Capsule every night. After that, all symptoms disappeared and did not recur for several years.

[0055] Case 7: Wang Lidong, male, 64 years old, from Hutouwang Village, Qianmotou Town, Shenzhou City, Hebei Province, presented on August 12, 1972, complaining of dizziness, tinnitus, discomfort in the back of the neck, and memory loss. His systolic blood pressure was 215 mmHg and diastolic blood pressure was 130 mmHg. His tongue was red and dry. His left pulse was wiry and forceful, while his right pulse was thin and rapid. He had previously taken nifedipine controlled-release tablets and amlodipine besylate tablets without any adverse effects. After consistently using the above medications for 30 days, his blood pressure remained around 130 / 80 mgHg without any discomfort. After continuing to take Anqi Pingya capsules for 60 days, his blood pressure stabilized without any adverse effects. The patient had no hypertension symptoms for more than a year.

[0056] The above are merely preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A method for preparing Anqi Pingya capsules, characterized in that, It includes the following components by weight: Astragalus membranaceus 6-7 parts, Codonopsis pilosula 6-7 parts, Salvia miltiorrhiza 4g, Paeonia suffruticosa 5-6 parts, Hordeum vulgare 5-6 parts, Crataegus pinnatifida 5-6 parts, Scutellaria baicalensis 3-4 parts, Bupleurum chinense 3-4 parts, Diazepam 2.5g, Nimodipine 1-2 parts, and Isatis indigotica 2-3 parts.

2. The method for preparing an astragalus-based pressure-relieving capsule according to claim 1, characterized in that, The aforementioned Anqi Pingya Capsules comprise the following components by weight: Astragalus membranaceus 6.25 parts, Codonopsis pilosula 6.25 parts, Salvia miltiorrhiza 4g, Paeonia suffruticosa 6 parts, Hordeum vulgare 6 parts, Crataegus pinnatifida 6 parts, Scutellaria baicalensis 4 parts, Bupleurum chinense 4 parts, Diazepam 0.25 parts, Nimodipine 2 parts, and Isatis indigotica 3 parts.

3. The method for preparing an astragalus-based pressure-relieving capsule according to claim 1, characterized in that, Includes the following steps: Step (1): Dry and grind the raw materials into fine powder and pass them through a mill. Then, take each raw material according to the weight ratio and mix them evenly to obtain an intermediate. Step (2): The intermediate obtained in step (1) is packaged into empty capsules. Step (3): The Anqi Pingya capsules prepared using the above method are 0.5g / capsule.